For laboratory research use onlyNot for human or veterinary use
10% off your first order. Use code WELCOME10 at checkout.One-week sale: Retatrutide 10 mg kit $100 (was $131) through Sep 28. New: Retatrutide 10 mg single vials now $25. See current offers

Blog

What the 2026 supplier roundups actually measure, and how to check any vendor yourself

The seven documentation criteria behind the 2026 research peptide supplier roundups, and a ten-minute check a laboratory buyer can run on any vendor.

Each year brings a fresh crop of “best research peptide company” roundups, and each one arranges a similar set of suppliers in a slightly different order. The ordering carries little information. The criteria underneath it carry a great deal, because once the promotional language is stripped out the 2026 lists converge on the same seven documentary questions — and a laboratory buyer can put those questions to any vendor directly rather than waiting for a roundup to do it.

What follows is a plain reading of those criteria, a check that runs in about ten minutes, and a statement of how Aegis Bio answers the same questions about its own lots. No vendor is named or ranked here. The method is the point, and it works on any catalogue, including this one.

The seven things the 2026 lists actually measure

1. A certificate of analysis for the lot, from a named third-party laboratory

The criterion that carries the most weight on every list. A specification sheet states what a material is supposed to be. A certificate of analysis states what one particular lot was measured to be, names the laboratory that did the measuring, and carries the lot identifier. A vendor publishing a blanket purity figure and nothing behind it has published a policy, not a measurement. The structure of a peptide certificate is standard enough that a buyer can learn to read one in an afternoon and then read every vendor’s the same way.

2. HPLC purity with the chromatogram attached

Area percent at a stated wavelength is the conventional purity figure, and it is only checkable when the trace behind it is included. The trace shows whether the remainder outside the main peak sits in one closely related impurity or is spread across a dozen small ones — two quite different materials that report the same headline number. Lists that score documentation rather than marketing weight an attached chromatogram well above a larger number with no trace.

3. Mass-spectrometry identity, observed against theoretical

Identity and purity answer separate questions. Mass spectrometry confirms the molecule matches the sequence named on the label; HPLC quantifies how much of the sample that molecule accounts for. A certificate carrying only one of the two is half a document. The difference between the two measurements is worth settling before certificates from different vendors are compared at all.

4. Lot traceability from catalogue code to certificate

A buyer should be able to move from the catalogue code on the order confirmation, to the lot number on the vial label, to the lot number at the head of the certificate, with no gap anywhere in the chain. Where the chain breaks, the certificate describes some material, but not demonstrably the material in the box. Roundups test this by asking for documentation on a named lot rather than on a product.

5. Transparent pricing per milligram

Price per vial is the easiest figure to compare and the least informative. Any list doing arithmetic divides by the labelled mass and sets cost per milligram side by side across formats, then notes whether the vendor states peptide content — the fraction of the powder that is peptide rather than water and counter-ion. Without that fraction the arithmetic carries an unstated error, commonly in the range of ten to twenty-five percent.

6. Unambiguous research-use-only positioning

A catalogue written for laboratories reads like one. Specifications, lot documentation, storage notes and shipping terms; no protocols, no outcomes, no language aimed at an individual reader. The 2026 lists score this directly and more heavily than earlier ones did, on the straightforward commercial reasoning that a supplier whose copy drifts is a supplier whose availability may be interrupted.

7. Payment and shipping terms stated up front

Flat-rate shipping bands, accepted payment methods, and the moment at which an order counts as placed — all published on the site rather than discovered at the final step. This is the cheapest criterion for a vendor to satisfy and therefore a useful signal when it is missing.

A ten-minute check any buyer can run

  1. Request the certificate of analysis for the lot that would actually ship. Not a sample certificate, not a previous lot. Note how long the reply takes.
  2. Open it and find the laboratory name. If none appears anywhere on the document, the analysis is self-reported.
  3. Find the chromatogram. A purity figure with no trace beneath it cannot be checked by anyone.
  4. Compare the observed mass against the theoretical mass for the sequence. A close match confirms identity; a gap is a question, not automatically a fault.
  5. Match the lot number on the certificate against the lot the vendor says would be supplied.
  6. Look for peptide content or net peptide weight. If it is absent, ask for it, and note whether the answer arrives as a figure or as reassurance.
  7. Divide price by labelled mass for every format in the listing, then add the shipping band. The ranking between formats frequently changes once shipping is included.
  8. Read the shipping and payment terms before anything goes into a cart.
  9. Read three product pages end to end. A catalogue written for laboratories will read consistently across all three.

Nine questions, one afternoon of practice, and thereafter about ten minutes per vendor. The longer guide to vetting on documentation covers what the answers mean once they arrive.

What a weak answer looks like

Rarely a refusal. Far more often a generic specification sheet sent in place of a lot certificate, a purity number quoted in an email with no attachment, a lot identifier that appears nowhere on the vial, or a long delay followed by a short answer. Speed and specificity separate suppliers more reliably than the content of any single reply, because both indicate whether the documentation already exists or is being assembled on demand.

How Aegis Bio documents its own lots

The same criteria, applied here. Lots are analysed by Janoshik Analytical, an independent laboratory commissioned by the manufacturer, covering HPLC purity and mass-spectrometry identity confirmation. Aegis Bio additionally submits selected lots to Accumark in California for its own independent verification, so that at least part of the record comes from a laboratory the manufacturer did not choose.

Materials are listed against a ≥99% HPLC purity specification, and the figure measured for a given lot is whatever that lot’s certificate states. The certificate for the lot supplied is available by request before an order is placed, and published certificates are collected in the certificate library. Requests for a specific lot go through the contact page; a catalogue code and the format under consideration are enough to identify it.

Everything on this site is supplied for in-vitro laboratory research use only.

Published for reference only. Nothing in this article is a therapeutic claim and no dosing guidance is provided. All materials are supplied for in-vitro laboratory research use only.

More from the blog

Browse the research catalog →